Sign Up to Download the Investor Presentation & Receive Updates
Invest in a Licensed Producer & Canada's Largest Supplier of Cannabis Genetics
THC BioMed Intl Ltd. (CSE: THC) is a Cannabis Act Licensed Producer and Canada's largest supplier of legal cannabis genetics.
The company operates on the leading edge of scientific research and the development of products and services for medical cannabis.
THC BioMed was one of the first companies cultivating and researching cannabis in Canada.
THC BioMed began selling award-winning pre-rolls and flower under supply agreements in 2018.
THC BioMed is the only LP shipping live marijuana clones to patients via its CloneShipper containers.
THC BioMed's management team has extensive experience within cannabis and finance sectors.
Reaching Consumers At Scale
THC BioMed recently automated their pre-rolls, containing 100% cannabis. With strong demand for pre-rolls, this could help bolster revenue and profitability by manufacturing at-scale. In addition, the pre-rolls contain a commercial-grade filter designed to help protect consumers without degrading the experience.
The Pure Cannabis automated pre-rolls are manufactured in a fully-automated facility that ensures a high level of consistency and quality.